Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List

10 months ago

Juniper Pharmaceuticals (Nasdaq:JNP), a diversified healthcare company focused on women’s health, today announced that Juniper Pharma Services co-founder Martyn Davies, PhD, has been appointed as a Commander of the Order of the British Empire (CBE) in Her Majesty’s 2018 New Year’s Honours List. The honours system recognises people who have made achievements in public life

Join us at AAPS in San Diego, November 12-15, 2017

12 months ago

AAPS meeting 2017 – Accelerating science to impact health Juniper Pharma Services will be attending the annual AAPS meeting in San Diego, November 12-15, 2017. Meet Juniper’s experts to discuss formulation development strategies and find out about our innovative product development solutions. Juniper has specialist knowledge in developing challenging molecules utilising a range of preclinical

Advancing Drug Development Forum in Boston, November 30, 2017

12 months ago

The Advancing Drug Development Forum has confirmed a prestigious line-up of leading industry voices to speak at its inaugural event. Taking place on November 30, 2017 in Boston, USA, the forum will see pharmaceutical experts and scientists from across the globe come together to exchange ideas and experiences and conduct a deep dive into the

Juniper Pharma Services and XenoGesis strengthen alliance in early drug development services

1 year ago

Nottingham, UK – Juniper Pharma Services and XenoGesis have extended their strategic alliance around their Enabling Technologies Rapid Screen through the addition of the gold standard PBPK modelling and simulation software, GastroPlusTM. This expanded partnership brings greater understanding of a compound’s potential exposure in both preclinical and clinical studies. Jointly they are already working in

Meet the team at CPhI in Frankfurt

1 year ago

Facing timescale issue to advance an internal product pipeline? Come and meet the team at #CPhI in Frankfurt in Hall 4, Stand 40D23 from 24-26th October, to discuss how we can help. Everything we do is shaped around the ethos of listening, understanding what you need, focusing on the job at hand, and then delivering

Major Progress in Next Generation Medicines Initiative

1 year ago

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reached a key milestone in its work with CrystecPharma and the Advanced Manufacturing Supply Chain Initiative (AMSCI) to create a new platform to accelerate drug development. The contract development and manufacturing organisation (CDMO) now has CrystecPharma’s supercritical fluid technology platform

Biotech Outsourcing Strategies (BOS) 2017

1 year ago

Juniper Pharma Services will be attending Biotech Outsourcing Strategies (BOS) which takes place on the 3rd October 2017 at the Royal College of Physicians in London. If you are attending the event and would like to meet with the team, get in touch to arrange a meeting.

Webinar – The Importance of Dose Prediction for Early Drug Development

1 year ago

Juniper Pharma Services will be presenting a webinar with Xenogesis: The Importance of Dose Prediction for Early Drug Development at 3.00pm (BST) on Thursday 6th July 2017. The webinar will examine how gaining a thorough understanding of the chemical and pharmacological attributes of a drug substance through preclinical studies is paramount for providing an effective dosage form

Juniper Pharma Services Brings PSD-1 Spray Dryer Online

1 year ago

Nottingham, UK – Juniper Pharma Services (“the company” or “Juniper”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has broadened its manufacturing capabilities bringing on-line its new spray dryer following the successful installation and validation of the advanced manufacturing equipment at its UK-based site. The contract development and manufacturing organisation (CDMO) has seen significant interest